Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Medical School

University of Cincinnati College of Medicine

1975, Cincinnati, OH

Internship

University Health Center of Pittsburgh

1977, Pittsburgh, PA

Residency

Harvard Combined Orthopedic Surgery Residency Program

1982, Boston, MA

Fellowship

Orthopedic Surgery

Boston Children's Hospital

1983, Boston, MA

Fellowship

Orthopedic Oncology

Massachusetts General Hospital

1983, Boston, MA

Certifications

  • American Board of Orthopedic Surgery (General)

Media

Answers Blog

Generations of excellence in caring for childhood bone cancers: Dr. Gebhardt and Dr. Anderson

Publications

  1. Editorial: An Update on How CORR Evaluates Systematic Reviews and Meta-analyses (Which You Might Also Consider When Reading Them). Clin Orthop Relat Res. 2025 Mar 01; 483(3):369-371. View Abstract

  2. Reply to the Letter to the Editor: Editorial: It's More Than Burnout-The Moral Injury Crisis in Orthopaedic Surgeons. Clin Orthop Relat Res. 2024 Jun 01; 482(6):1092-1093. View Abstract

  3. Editorial: Uses of Generative Artificial Intelligence in Clinical Orthopaedics and Related Research®-An Update. Clin Orthop Relat Res. 2024 Jun 01; 482(6):909-911. View Abstract

  4. Editorial: Allyship-Not the Solution, But a Way Forward. Clin Orthop Relat Res. 2024 Feb 01; 482(2):217-218. View Abstract

  5. Editorial: It's More Than Burnout-The Moral Injury Crisis in Orthopaedic Surgeons. Clin Orthop Relat Res. 2023 Nov 01; 481(11):2073-2075. View Abstract

  6. Management of limb length discrepancy after bone sarcoma resection about the knee in the skeletally immature. J Pediatr Orthop B. 2024 Sep 01; 33(5):497-502. View Abstract

  7. A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. Cancer Med. 2023 06; 12(12):13300-13308. View Abstract

  8. What is the Value of Radiology Input During a Multidisciplinary Orthopaedic Oncology Conference? Clin Orthop Relat Res. 2023 10 01; 481(10):2005-2013. View Abstract

  9. Editorial: Re-examining How We Study Race and Ethnicity. Clin Orthop Relat Res. 2023 03 01; 481(3):419-421. View Abstract

  10. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma. Cancer. 2023 01 01; 129(1):60-70. View Abstract

  11. Editorial: What CORR® Seeks From Papers About New Implants and Techniques. Clin Orthop Relat Res. 2022 Oct 01; 480(10):1843-1845. View Abstract

  12. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. Clin Orthop Relat Res. 2023 03 01; 481(3):526-538. View Abstract

  13. Editorial: Retirement-Dread or Dream? Reflections on Transitioning to a New Phase of Life. Clin Orthop Relat Res. 2022 04 01; 480(4):639-641. View Abstract

  14. Oncological and Functional Outcomes in Joint-sparing Resections of the Proximal Femur for Malignant Primary Bone Tumors. J Pediatr Orthop. 2021 Sep 01; 41(8):e680-e685. View Abstract

  15. Current Orthopaedic Residency Letters of Recommendation Are Not Biased by Gender of Applicant. JB JS Open Access. 2021 Jul-Sep; 6(3). View Abstract

  16. Editorial: Opposites Attract at CORR®-Machine Learning and Qualitative Research. Clin Orthop Relat Res. 2020 10; 478(10):2193-2196. View Abstract

  17. Pain management research. Spine J. 2020 08; 20(8):1165-1166. View Abstract

  18. Pain Management Research. Foot Ankle Int. 2020 06; 41(6):761-762. View Abstract

  19. Pain Management Research. J Bone Joint Surg Am. 2020 05 20; 102(10):855. View Abstract

  20. Tumors of the scapula: A retrospective analysis identifying predictors of malignancy. Surg Oncol. 2020 Mar; 32:18-22. View Abstract

  21. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50. View Abstract

  22. Functional Outcomes and Complications After Oncologic Reconstruction of the Proximal Humerus. J Am Acad Orthop Surg. 2018 Jun 01; 26(11):403-409. View Abstract

  23. Editorial: The Complexity of Reporting Race and Ethnicity in Orthopaedic Research. Clin Orthop Relat Res. 2018 05; 476(5):917-920. View Abstract

  24. Editorial: Sara's Story. Clin Orthop Relat Res. 2018 02; 476(2):177-178. View Abstract

  25. Erratum to: Editorial: Do Orthopaedic Surgeons Belong on the Sidelines at American Football Games? Clin Orthop Relat Res. 2017 12; 475(12):3118. View Abstract

  26. Editorial: Do Orthopaedic Surgeons Belong on the Sidelines at American Football Games? Clin Orthop Relat Res. 2017 11; 475(11):2615-2618. View Abstract

  27. Editorial: How Does CORR ® Evaluate Survey Studies? Clin Orthop Relat Res. 2017 09; 475(9):2143-2145. View Abstract

  28. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets. J Hematol Oncol. 2017 05 15; 10(1):107. View Abstract

  29. MRI guided needle localization in a patient with recurrence pleomorphic sarcoma and post-operative scarring. Skeletal Radiol. 2017 Jul; 46(7):975-981. View Abstract

  30. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408. View Abstract

  31. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. Ann Surg Oncol. 2016 10; 23(11):3541-3547. View Abstract

  32. Predictors of soft-tissue complications and deep infection in allograft reconstruction of the proximal tibia. J Surg Oncol. 2016 Jun; 113(7):811-7. View Abstract

  33. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2016 10; 63(10):1737-43. View Abstract

  34. Ipsilateral Nonvascularized Autograft and Periosteal Repair for the Treatment of Pediatric Tumors of the Distal Fibula. Orthopedics. 2016 Jul 01; 39(4):e687-94. View Abstract

  35. CT-based Structural Rigidity Analysis Is More Accurate Than Mirels Scoring for Fracture Prediction in Metastatic Femoral Lesions. Clin Orthop Relat Res. 2016 Mar; 474(3):643-51. View Abstract

  36. Does CT-based Rigidity Analysis Influence Clinical Decision-making in Simulations of Metastatic Bone Disease? Clin Orthop Relat Res. 2016 Mar; 474(3):652-9. View Abstract

  37. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61. View Abstract

  38. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. J Clin Oncol. 2015 Jul 10; 33(20):2279-87. View Abstract

  39. Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis. Clin Cancer Res. 2015 Jun 01; 21(11):2514-9. View Abstract

  40. Editorial: Estimating survivorship in the face of competing risks. Clin Orthop Relat Res. 2015 Apr; 473(4):1173-6. View Abstract

  41. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer. 2015 Feb 01; 121(3):467-75. View Abstract

  42. Editorial: Words hurt--avoiding dehumanizing language in orthopaedic research and practice. Clin Orthop Relat Res. 2014 Sep; 472(9):2561-3. View Abstract

  43. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls. Orthop Clin North Am. 2014 Jul; 45(3):403-16. View Abstract

  44. Surgical treatment of osteochondroma of the proximal humerus: radiographic and early clinical results. J Pediatr Orthop. 2014 Jul-Aug; 34(5):529-33. View Abstract

  45. Aneurysmal Bone Cyst of the Patella Mimicking Patellofemoral Syndrome: A Case Report. JBJS Case Connect. 2014 May 28; 4(2):e39. View Abstract

  46. Non-neoplastic soft tissue masses that mimic sarcoma. Orthop Clin North Am. 2014 Apr; 45(2):245-55. View Abstract

  47. Fairness to all: gender and sex in scientific reporting. Clin Orthop Relat Res. 2014 Feb; 472(2):391-2. View Abstract

  48. Active management of financial conflicts of interest on the Editorial Board of CORR. Clin Orthop Relat Res. 2013 Nov; 471(11):3393-4. View Abstract

  49. Proximal tibial pain in a child. Skeletal Radiol. 2013 Sep; 42(9):1333-6. View Abstract

  50. Proximal tibial pain in a child. Skeletal Radiol. 2013 Sep; 42(9):1297-9, 1333-6. View Abstract

  51. Knee pain in a 9-year-old girl. Clin Orthop Relat Res. 2013 Oct; 471(10):3367-71. View Abstract

  52. Epiphyseal lesion of the humerus in a child. Solitary epiphyseal enchondroma of the humeral greater tuberosity. Skeletal Radiol. 2013 Jul; 42(7):1001-2, 1021-3. View Abstract

  53. Resolving bony abnormality evolves to diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2013 Oct; 60(10):E113-5. View Abstract

  54. Guest editorial: Patriots' Day at the Boston Marathon. Clin Orthop Relat Res. 2013 Jul; 471(7):2045-6. View Abstract

  55. MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32. Genome Med. 2013; 5(1):2. View Abstract

  56. Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study. BMJ Open. 2012; 2(6). View Abstract

  57. EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors. Clin Cancer Res. 2012 Oct 01; 18(19):5341-51. View Abstract

  58. A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study. BMC Genomics. 2012 Jul 23; 13:332. View Abstract

  59. SAR simulations for high-field MRI: how much detail, effort, and accuracy is needed? Magn Reson Med. 2013 Apr; 69(4):1157-68. View Abstract

  60. Effects of one-lung ventilation on thermodilution-derived assessment of cardiac output. Br J Anaesth. 2012 Jun; 108(6):922-8. View Abstract

  61. Highlights of the ISOLS/MSTS 2009 meeting: editorial comment. Clin Orthop Relat Res. 2010 Nov; 468(11):2829-30. View Abstract

  62. Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities. Clin Orthop Relat Res. 2010 Nov; 468(11):3019-27. View Abstract

  63. Computed tomography-based structural analysis for predicting fracture risk in children with benign skeletal neoplasms: comparison of specificity with that of plain radiographs. J Bone Joint Surg Am. 2010 Aug 04; 92(9):1827-33. View Abstract

  64. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Res. 2010 Jul 01; 70(13):5577-86. View Abstract

  65. Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance. PLoS One. 2010 Apr 01; 5(4):e9747. View Abstract

  66. An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):843-50. View Abstract

  67. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol. 2009 May 20; 27(15):2536-41. View Abstract

  68. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Sep; 51(3):334-8. View Abstract

  69. Osteoblastoma: a 30-year study of 99 cases. J Surg Oncol. 2008 Sep 01; 98(3):179-83. View Abstract

  70. A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Med Wkly. 2008 Aug 09; 138(31-32):453-8. View Abstract

  71. Unicameral bone cyst: a retrospective study of three surgical treatments. Clin Orthop Relat Res. 2008 Oct; 466(10):2519-26. View Abstract

  72. Complications and risk factors for failure of rotationplasty: review of 25 patients. Clin Orthop Relat Res. 2008 Jun; 466(6):1302-8. View Abstract

  73. Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal. Am J Surg Pathol. 2008 Mar; 32(3):363-76. View Abstract

  74. Orthopedic board certification and physician performance: an analysis of medical malpractice, hospital disciplinary action, and state medical board disciplinary action rates. Am J Orthop (Belle Mead NJ). 2008 Feb; 37(2):73-5. View Abstract

  75. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol. 2008 Feb 01; 26(4):633-8. View Abstract

  76. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer. 2007 Dec; 49(7):894-900. View Abstract

  77. Are fibula strut allografts a reliable alternative for periarticular reconstruction after curettage for bone tumors? Clin Orthop Relat Res. 2007 Aug; 461:170-4. View Abstract

  78. Novel karyotypes in giant cell-rich lesions of bone. Am J Surg Pathol. 2007 Jun; 31(6):926-32. View Abstract

  79. Imaging of pseudoneoplastic masses associated with allografts. Skeletal Radiol. 2007 Aug; 36(8):747-53. View Abstract

  80. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1460-9. View Abstract

  81. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol. 2007 Feb 10; 25(5):501-6. View Abstract

  82. Improving diversity in orthopaedic residency programs. J Am Acad Orthop Surg. 2007; 15 Suppl 1:S49-50. View Abstract

  83. Perspectives on health disparities in orthopaedic oncology. J Am Acad Orthop Surg. 2007; 15 Suppl 1:S5-7. View Abstract

  84. The conduct of clinical research under the HIPAA Privacy Rule. J Bone Joint Surg Am. 2006 Dec; 88(12):2765-70. View Abstract

  85. Results of free vascularized fibula grafting for allograft nonunion after limb salvage surgery for malignant bone tumors. J Pediatr Orthop. 2006 Nov-Dec; 26(6):809-14. View Abstract

  86. Locking versus standard plates for allograft fixation after tumor resection in children and adolescents. J Pediatr Orthop. 2006 Sep-Oct; 26(5):680-5. View Abstract

  87. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol. 2006 Aug 20; 24(24):3838-43. View Abstract

  88. Improved survival for sarcomas of the wrist and hand. J Hand Surg Am. 2006 Mar; 31(3):452-5. View Abstract

  89. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. J Clin Oncol. 2006 Jan 01; 24(1):152-9. View Abstract

  90. Predicting fracture through benign skeletal lesions with quantitative computed tomography. J Bone Joint Surg Am. 2006 Jan; 88(1):55-70. View Abstract

  91. Results of radiation therapy performed after unplanned surgery (without re-excision) for soft tissue sarcomas. J Surg Oncol. 2005 Oct 01; 92(1):39-45. View Abstract

  92. Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol. 2005 Sep 20; 23(27):6756-62. View Abstract

  93. Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop Relat Res. 2005 Sep; 438:144-8. View Abstract

  94. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene. 2005 May 12; 24(21):3419-26. View Abstract

  95. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005 Mar 20; 23(9):2004-11. View Abstract

  96. Case records of the Massachusetts General Hospital. Case 8-2005. A 10-year-old boy with pain in the right thigh. N Engl J Med. 2005 Mar 17; 352(11):1122-9. View Abstract

  97. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol. 2005 Jun 20; 23(18):4031-8. View Abstract

  98. Multicenter clinical trials in orthopaedics: time for musculoskeletal specialty societies to take action. J Bone Joint Surg Am. 2005 Jan; 87(1):214-7. View Abstract

  99. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res. 2004 Dec; (429):286-91. View Abstract

  100. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004 Nov; 165(5):1773-80. View Abstract

  101. Survival data for patients with malignant schwannoma. Clin Orthop Relat Res. 2004 Sep; (426):69-73. View Abstract

  102. Long-term effects of connective tissue cancer treatment. Clin Orthop Relat Res. 2004 Sep; (426):74-86. View Abstract

  103. Malignant tumors of the pelvis: an outcome study. Clin Orthop Relat Res. 2004 Aug; (425):212-7. View Abstract

  104. Distinct chromosomal rearrangements in subungual (Dupuytren) exostosis and bizarre parosteal osteochondromatous proliferation (Nora lesion). Am J Surg Pathol. 2004 Aug; 28(8):1033-9. View Abstract

  105. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol. 2004 Jul 15; 22(14):2873-6. View Abstract

  106. Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int. 2004 May; 25(5):325-30. View Abstract

  107. Leiomyosarcoma of somatic soft tissues. Clin Orthop Relat Res. 2004 Apr; (421):225-31. View Abstract

  108. Allografts about the Knee in Young Patients with High-Grade Sarcoma. Clin Orthop Relat Res. 2004 Apr; (421):232-9. View Abstract

  109. Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res. 2004 Mar; (420):239-50. View Abstract

  110. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9(4):422-41. View Abstract

  111. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res. 2003 Nov 15; 9(15):5442-53. View Abstract

  112. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg. 2003 Oct; 238(4):563-7; discussion 567-8. View Abstract

  113. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003 Oct; 229(1):171-5. View Abstract

  114. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003 Jul 15; 56(4):1117-27. View Abstract

  115. Metachronous osteosarcoma: a report of five cases. Clin Orthop Relat Res. 2003 Jun; (411):227-35. View Abstract

  116. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003 Apr 15; 21(8):1574-80. View Abstract

  117. What's new in musculoskeletal oncology. J Bone Joint Surg Am. 2003 Apr; 85(4):761-7. View Abstract

  118. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003 Feb 20; 348(8):694-701. View Abstract

  119. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, Boston. J Pediatr Hematol Oncol. 2002 Dec; 24(9):722-6. View Abstract

  120. Allograft arthrodesis treatment of bone tumors: a two-center study. Clin Orthop Relat Res. 2002 Jul; (400):217-24. View Abstract

  121. Surgical treatment of hemangiomas of soft tissue. Clin Orthop Relat Res. 2002 Jun; (399):205-10. View Abstract

  122. Intracortical chondroma simulating osteoid osteoma treated by radiofrequency. Skeletal Radiol. 2002 Oct; 31(10):597-602. View Abstract

  123. What's new in musculoskeletal oncology. J Bone Joint Surg Am. 2002 Apr; 84(4):694-701. View Abstract

  124. The use of flow cytometry in assessing malignancy in bone and soft tissue tumors. Clin Orthop Relat Res. 2002 Apr; (397):95-105. View Abstract

  125. Long-term followup of proximal femoral allografts. Clin Orthop Relat Res. 2002 Apr; (397):106-13. View Abstract

  126. Repair of bone allograft fracture using bone morphogenetic protein-2. Clin Orthop Relat Res. 2002 Apr; (397):119-26. View Abstract

  127. Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol. 2002 Jun; 31(6):349-53. View Abstract

  128. Clinical outcome in chordoma: utility of flow cytometry in DNA determination. Spine (Phila Pa 1976). 2002 Feb 15; 27(4):374-9. View Abstract

  129. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol. 2002 Jan 15; 20(2):426-33. View Abstract

  130. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am. 2002 Jan; 84(1):49-57. View Abstract

  131. Primary treatment of chondroblastoma with percutaneous radio-frequency heat ablation: report of three cases. Radiology. 2001 Nov; 221(2):463-8. View Abstract

  132. Management of infected bulk allografts with antibiotic-impregnated polymethylmethacrylate spacers. Orthopedics. 2001 Oct; 24(10):971-5. View Abstract

  133. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol. 2001 Aug-Sep; 23(6):340-8. View Abstract

  134. The effect of adjuvant chemotherapy on osteoarticular allografts. Clin Orthop Relat Res. 2001 Apr; (385):176-81. View Abstract

  135. What's new in musculoskeletal tumor surgery. J Bone Joint Surg Am. 2001 Apr; 83(4):629-34. View Abstract

  136. Intra-articular lipoma with osteochondroid metaplasia in the knee joint. Skeletal Radiol. 2001 Apr; 30(4):230-3. View Abstract

  137. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors. Anticancer Res. 2001 Mar-Apr; 21(2B):1271-7. View Abstract

  138. Primary osteosarcoma of the distal femur in two consecutive brothers. Clin Orthop Relat Res. 2001 Jan; (382):191-6. View Abstract

  139. Allograft fractures revisited. Clin Orthop Relat Res. 2001 Jan; (382):66-74. View Abstract

  140. Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res. 2001 Jan; (382):87-98. View Abstract

  141. Osteochondromas of the distal aspect of the tibia or fibula. Natural history and treatment. J Bone Joint Surg Am. 2000 Sep; 82(9):1269-78. View Abstract

  142. Parosteal osteosarcoma of the posterior aspect of the distal part of the femur. Oncological and functional results following a new resection technique. J Bone Joint Surg Am. 2000 Aug; 82(8):1083-8. View Abstract

  143. Chondroblastoma of bone. J Bone Joint Surg Am. 2000 Aug; 82(8):1140-5. View Abstract

  144. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. J Bone Joint Surg Am. 2000 Jul; 82-A(7):963-9. View Abstract

  145. Complications of irradiated allografts in orthopaedic tumor surgery. Clin Orthop Relat Res. 2000 Jun; (375):214-7. View Abstract

  146. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun; 119(6):1154-61. View Abstract

  147. Multiple lytic skeletal lesions and hypercalcemia in a 13-year-old girl. Clin Orthop Relat Res. 2000 May; (374):298-302, 317-9. View Abstract

  148. P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Clin Orthop Relat Res. 2000 Apr; (373):11-7. View Abstract

  149. Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model. Br J Cancer. 2000 Apr; 82(7):1327-31. View Abstract

  150. Intraosseus teratoma of the iliac bone. Pediatr Radiol. 2000 Apr; 30(4):258-61. View Abstract

  151. Polyploidization induced by acridine orange in mouse osteosarcoma cells. Anticancer Res. 2000 Mar-Apr; 20(2A):965-70. View Abstract

  152. Experimental model for allograft incorporation and allograft fracture repair. J Orthop Res. 2000 Mar; 18(2):303-6. View Abstract

  153. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol. 1999 Nov-Dec; 21(6):486-93. View Abstract

  154. Tumor reconstruction. Orthop Clin North Am. 1999 Oct; 30(4):673-84. View Abstract

  155. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr. 1999 Oct 01; 22(2):174-9. View Abstract

  156. Extraskeletal myxoid chondrosarcoma of the knee. Skeletal Radiol. 1999 Jun; 28(6):354-8. View Abstract

  157. Decreasing length of hospital stay in treatment of osteoid osteoma. Clin Orthop Relat Res. 1999 Apr; (361):186-91. View Abstract

  158. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999 Mar; 81(3):326-38. View Abstract

  159. Development of occupational skin diseases during vocational training in baker and confectioner apprentices: a follow-up study. Contact Dermatitis. 1998 Dec; 39(6):307-11. View Abstract

  160. A discrete soft tissue mass in the distal thigh of a 29-year-old man. Clin Orthop Relat Res. 1998 Dec; (357):247-50, 255-6. View Abstract

  161. Orthopaedic workforce in the next millennium. J Bone Joint Surg Am. 1998 Oct; 80(10):1533-51. View Abstract

  162. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol. 1998 Sep; 16(9):3021-7. View Abstract

  163. Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland. Swiss HIV Cohort Study. AIDS. 1998 Jul 09; 12(10):1195-201. View Abstract

  164. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am. 1998 Jun; 80(6):815-21. View Abstract

  165. Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance. Cancer Lett. 1998 Apr 10; 126(1):75-81. View Abstract

  166. Reconstruction of the distal aspect of the radius with use of an osteoarticular allograft after excision of a skeletal tumor. J Bone Joint Surg Am. 1998 Mar; 80(3):407-19. View Abstract

  167. Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys. 1998 Feb 01; 40(3):637-45. View Abstract

  168. Pain and weakness of the shoulder in a 16-year-old boy. Clin Orthop Relat Res. 1998 Feb; (347):268-71, 287-90. View Abstract

  169. Diagnosis and treatment of unicameral and aneurysmal bone cysts in children. Curr Opin Pediatr. 1998 Feb; 10(1):87-94. View Abstract

  170. Role of glutathione in cisplatin resistance in osteosarcoma cell lines. J Orthop Res. 1998 Jan; 16(1):15-22. View Abstract

  171. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression. Cancer. 1997 Dec 15; 80(12):2230-9. View Abstract

  172. A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix. Hum Genet. 1997 Dec; 101(2):165-9. View Abstract

  173. Monitoring of serologic immune parameters in inflammatory skin diseases. Allergy. 1997 Nov; 52(11):1087-94. View Abstract

  174. Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery. Semin Oncol. 1997 Oct; 24(5):540-6. View Abstract

  175. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997 Oct; 131(4):603-7. View Abstract

  176. Scintigraphy of lower extremity cadaveric bone allografts in osteosarcoma patients. Clin Nucl Med. 1997 Aug; 22(8):532-5. View Abstract

  177. Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer. 1997 Apr 01; 79(7):1343-50. View Abstract

  178. The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study. J Bone Joint Surg Am. 1997 Jan; 79(1):97-106. View Abstract

  179. NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996 Dec; 10(12):1799-806, 1812. View Abstract

  180. Pediatric musculoskeletal neoplasms. Evaluation with MR imaging. Magn Reson Imaging Clin N Am. 1996 Nov; 4(4):749-70. View Abstract

  181. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med. 1996 Oct 03; 335(14):1029-33. View Abstract

  182. Symptomatic forearm mass in a 48-year-old man. Clin Orthop Relat Res. 1996 Oct; (331):308-9, 312-4. View Abstract

  183. SV40-like sequences in human bone tumors. Oncogene. 1996 Aug 01; 13(3):527-35. View Abstract

  184. Molecular biology of sarcomas. Orthop Clin North Am. 1996 Jul; 27(3):421-9. View Abstract

  185. The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop Relat Res. 1996 Mar; (324):227-32. View Abstract

  186. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res. 1996 Mar; (324):86-97. View Abstract

  187. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. J Bone Joint Surg Am. 1996 Mar; 78(3):366-75. View Abstract

  188. P-glycoprotein is expressed in the mineralizing regions of the skeleton. Calcif Tissue Int. 1996 Mar; 58(3):186-91. View Abstract

  189. Chondrosarcoma: a review. Instr Course Lect. 1996; 45:417-24. View Abstract

  190. Osteoid osteoma: percutaneous radio-frequency ablation. Radiology. 1995 Nov; 197(2):451-4. View Abstract

  191. Role of surgical resection in pelvic Ewing's sarcoma. J Clin Oncol. 1995 Sep; 13(9):2336-41. View Abstract

  192. p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event. Clin Mol Pathol. 1995 Apr; 48(2):M79-82. View Abstract

  193. Transforming growth factor-beta: possible roles in Dupuytren's contracture. J Hand Surg Am. 1995 Jan; 20(1):101-8. View Abstract

  194. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994 Dec; 76(12):1827-33. View Abstract

  195. Quality of life in osteosarcoma survivors. Oncology (Williston Park). 1994 Nov; 8(11):19-25; discussion 25-6, 32, 35. View Abstract

  196. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes. Cancer Genet Cytogenet. 1994 Oct; 77(1):81-8. View Abstract

  197. An assay to measure adriamycin binding in osteosarcoma cells. J Orthop Res. 1994 Sep; 12(5):621-7. View Abstract

  198. Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells. Int J Cancer. 1994 Aug 01; 58(3):440-5. View Abstract

  199. Case report 830: Aneurysmal bone cyst. Skeletal Radiol. 1994 Feb; 23(2):157-60. View Abstract

  200. Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Med Pediatr Oncol. 1994; 23(4):354-8. View Abstract

  201. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines. Eur J Cancer. 1994; 30A(5):678-82. View Abstract

  202. [Effects of the 1987 revision of the definition for an AIDS case in Switzerland]. Soz Praventivmed. 1994; 39(3):134-42. View Abstract

  203. Pediatric bone tumors. Compr Ther. 1993; 19(2):73-81. View Abstract

  204. Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). Hum Mutat. 1993; 2(4):274-85. View Abstract

  205. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993 Jan; (286):241-6. View Abstract

  206. Current status of allografting for bone tumors. Orthopedics. 1992 Oct; 15(10):1147-54. View Abstract

  207. No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lung. Genes Chromosomes Cancer. 1992 Sep; 5(2):97-103. View Abstract

  208. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14; 326(20):1309-15. View Abstract

  209. [Tumor diseases in families of 600 breast cancer patients with special reference to familial adenocarcinomatosis and the Li-Fraumeni-/SBLA syndrome]. Helv Chir Acta. 1992 May; 59(1):239-45. View Abstract

  210. In vitro assay of nuclear uptake of doxorubicin hydrochloride in osteosarcoma cells of dogs. Am J Vet Res. 1991 Dec; 52(12):1951-5. View Abstract

  211. Flow cytometric studies of human osteosarcoma. Clin Orthop Relat Res. 1991 Sep; (270):169-80. View Abstract

  212. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop Relat Res. 1991 Sep; (270):181-96. View Abstract

  213. Rotationplasty as a reconstructive operation after tumor resection. Clin Orthop Relat Res. 1991 Sep; (270):231-6. View Abstract

  214. Massive bone allografts for traumatic skeletal defects. South Med J. 1991 Aug; 84(8):975-82. View Abstract

  215. Osteosarcoma in young children. Cancer. 1991 Feb 01; 67(3):638-42. View Abstract

  216. Allograft reconstructions of the shoulder after bone tumor resections. Orthop Clin North Am. 1991 Jan; 22(1):37-48. View Abstract

  217. Principles of surgical treatment of soft tissue sarcomas. Cancer Treat Res. 1991; 56:37-52. View Abstract

  218. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 1990 Nov; 10(11):5772-81. View Abstract

  219. Effects of propane-2, 2-diphosphonate (PDP) on matrix-induced ectopic bone formation in comparison to ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Clin Orthop Relat Res. 1990 Sep; (258):122-34. View Abstract

  220. Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am. 1990 Jul; 72(6):825-33. View Abstract

  221. Tumors about the knee in children. Clin Orthop Relat Res. 1990 Jun; (255):86-110. View Abstract

  222. Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor. J Bone Joint Surg Am. 1990 Mar; 72(3):334-45. View Abstract

  223. DNA ploidy as a prognostic indicator in human osteosarcoma. Chir Organi Mov. 1990; 75(1 Suppl):18-21. View Abstract

  224. A system for the classification of skeletal resections. Chir Organi Mov. 1990; 75(1 Suppl):217-40. View Abstract

  225. Effect of preoperative chemotherapy on nuclear DNA content in osteosarcoma. Chir Organi Mov. 1990; 75(1 Suppl):22-4. View Abstract

  226. Chronic tibial lesions. Chir Organi Mov. 1990; 75(1 Suppl):247-8. View Abstract

  227. Growth factor production by sarcoma cells in primary culture. J Orthop Res. 1989; 7(4):468-73. View Abstract

  228. Timing of chemotherapy and surgery in a murine osteosarcoma model. Cancer Res. 1988 Oct 01; 48(19):5533-8. View Abstract

  229. Postradiation multicentric osteosarcoma. Cancer. 1988 Jul 01; 62(1):67-71. View Abstract

  230. Percutaneous biopsy of pyogenic infection of the spine in children. J Pediatr Orthop. 1988 Jul-Aug; 8(4):442-4. View Abstract

  231. The use of flow cytometry as a diagnostic aid in the management of soft-tissue tumors. J Bone Joint Surg Am. 1988 Jun; 70(5):751-9. View Abstract

  232. Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol. 1988 May; 6(5):854-62. View Abstract

  233. Reconstruction for defects of the proximal part of the femur using allograft arthroplasty. J Bone Joint Surg Am. 1988 Apr; 70(4):507-16. View Abstract

  234. Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am. 1988 Mar; 70(3):369-76. View Abstract

  235. Evaluation of fluorescein diacetate for flow cytometric determination of cell viability in orthopaedic research. J Orthop Res. 1988; 6(4):467-74. View Abstract

  236. Kinetic effects of adriamycin and bleomycin on two osteosarcoma models. J Orthop Res. 1988; 6(1):51-7. View Abstract

  237. Spontaneous rupture of the extensor pollicis longus tendon. J Hand Surg Am. 1987 Nov; 12(6):1106-9. View Abstract

  238. The treatment of adamantinoma of the tibia by wide resection and allograft bone transplantation. J Bone Joint Surg Am. 1987 Oct; 69(8):1177-88. View Abstract

  239. Intra-articular entrapment of the median nerve after elbow dislocation in children. J Hand Surg Am. 1987 Sep; 12(5 Pt 1):704-7. View Abstract

  240. Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III. J Clin Oncol. 1987 Aug; 5(8):1178-84. View Abstract

  241. Methods of banking bone and cartilage for allograft transplantation. Orthop Clin North Am. 1987 Apr; 18(2):241-7. View Abstract

  242. The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities. Orthop Clin North Am. 1987 Apr; 18(2):275-89. View Abstract

  243. MRI in stress fracture. AJR Am J Roentgenol. 1986 Sep; 147(3):553-6. View Abstract

  244. Extraosseous osteosarcoma presenting with intestinal hemorrhage: case report and literature review. Hum Pathol. 1986 Jan; 17(1):85-7. View Abstract

  245. Advances in the management of bone tumors. Clin Orthop Relat Res. 1985 Nov; (200):73-84. View Abstract

  246. Prostaglandin E2 synthesis by human primary and metastatic bone tumors in culture. Clin Orthop Relat Res. 1985 Jun; (196):300-5. View Abstract

  247. Desmoplastic fibroma of bone. A report of eight cases and review of the literature. J Bone Joint Surg Am. 1985 Jun; 67(5):732-47. View Abstract

  248. Magnetic resonance imaging in a patient with soft tissue sarcoma of the leg. Orthopedics. 1985 Mar; 8(3):369-72. View Abstract

  249. Bone tumors in children. Differential characteristics and treatment. Postgrad Med. 1984 Sep 15; 76(4):87-96. View Abstract

  250. NMR imaging of forearms in healthy volunteers and patients with giant-cell tumor of bone. Radiology. 1982 Aug; 144(3):549-52. View Abstract

  251. Bilateral lateral discoid meniscus in identical twins. J Bone Joint Surg Am. 1979 Oct; 61(7):1110-1. View Abstract

  252. Effect of Corynebacterium parvum on liver proliferation and regeneration. Cancer Res. 1979 Apr; 39(4):1361-8. View Abstract

  253. Further observations on the inhibition of tumor growth by C. parvum with cyclophosphamide. VII. Effect of treatment prior to primary tumor removal on the growth of distant tumor. Cancer. 1979 Feb; 43(2):451-8. View Abstract

  254. The evolution of breast cancer surgery: past, present, and future. Semin Oncol. 1978 Dec; 5(4):385-94. View Abstract

  255. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII. Int J Radiat Oncol Biol Phys. 1978 Nov-Dec; 4(11-12):975-82. View Abstract

  256. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide. Cancer Res. 1978 Sep; 38(9):2679-87. View Abstract

  257. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction. Cancer Res. 1978 Jan; 38(1):38-41. View Abstract

  258. Psychotropic drugs on general medical and surgical wards of a teaching hospital. Arch Gen Psychiatry. 1975 Apr; 32(4):507-11. View Abstract

  259. Brushite octacalcium phosphate, and carbonate-containing apatite in bone. Clin Orthop Relat Res. 1973 Jan-Feb; (90):271-3. View Abstract

  260. [Parossal sarcoma. Clinical aspects, histology, ultrastructure and mineralogy]. Z Orthop Ihre Grenzgeb. 1971 Mar; 109(1):114-23. View Abstract

  261. [Hazards of tuberculosis infection and morbidity in the present epidemiologic situation in the Federal Republic of Germany. Findings in Schleswig-Holstein]. Pneumonologie. 1971; 145:10-9. View Abstract

  262. [The grade of cristallization and the type of minerals in bones depending on age and localization]. Z Orthop Ihre Grenzgeb. 1970 Jul; 108(1):104-12. View Abstract
BESbswy